Jasper Therapeutics, Inc. (JSPR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 01:01PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 319.66M |
| Enterprise Value | 235.56M |
| Trailing P/E | 0.53 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.08 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.48 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.25 |
| 52-Week Change 3 | 42.21% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 31.01 |
| 52 Week Low 3 | 4.00 |
| 50-Day Moving Average 3 | 25.33 |
| 200-Day Moving Average 3 | 13.79 |
Share Statistics
| Avg Vol (3 month) 3 | 102.03k |
| Avg Vol (10 day) 3 | 66.06k |
| Shares Outstanding 5 | 15.09M |
| Implied Shares Outstanding 6 | 15.09M |
| Float 8 | 9.47M |
| % Held by Insiders 1 | 4.99% |
| % Held by Institutions 1 | 61.53% |
| Shares Short (Apr 15, 2024) 4 | 492.42k |
| Short Ratio (Apr 15, 2024) 4 | 4.96 |
| Short % of Float (Apr 15, 2024) 4 | 3.31% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 3.26% |
| Shares Short (prior month Mar 15, 2024) 4 | 327.3k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jan 04, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -60.09% |
| Return on Equity (ttm) | -112.67% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -67.75M |
| Net Income Avi to Common (ttm) | -64.47M |
| Diluted EPS (ttm) | -61.80 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.89M |
| Total Cash Per Share (mrq) | 5.77 |
| Total Debt (mrq) | 2.79M |
| Total Debt/Equity (mrq) | 3.55% |
| Current Ratio (mrq) | 7.19 |
| Book Value Per Share (mrq) | 7.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -52.07M |
| Levered Free Cash Flow (ttm) | -30.35M |
© 2024 Yahoo. All rights reserved.